Clinical outcomes. Improved
Huma's EU MDR Class IIb approved and Class II FDA 510(k) cleared platform as a medical device platform enables faster, smarter symptom tracking and clinical decision-making, resulting in earlier interventions, better patient experiences and improved outcomes.
With a single view of the patient on one convenient dashboard, clinicians can identify at-risk patients earlier and make timely interventions sooner—especially for patients with multiple comorbidities.
Improve clinical outcomes
adherence and retention rates across our care and research deployments are the result of high engagement rates1
Our platform can almost double clinical capacity and reduce readmission rates by >30%2
lower mortality amongst Huma patients compared with patients not using Huma3
of patients highlighted as deteriorating had operation dates brought forward4
Positively impact patient health outcomes with smart insights
Huma’s scalable platform gives you access to aggregated data in one convenient dashboard, including digital biomarker data and ePROs. Clinician-configurable RAG indicators help to quickly flag patients in need of treatment review or intervention.
Higher acuity patients at risk of deterioration can be monitored remotely on the platform for a longer period of time, rather than simply escalating all at-risk patients to the ED.
Our platform provides personalised and adaptive direction on treatment interventions, leveraging processed input data, including novel AI-driven algorithms and digital biomarkers.
.png)
Positively impact patient health outcomes with smart insights
Higher acuity patients at risk of deterioration can be monitored remotely on the platform for a longer period of time, rather than simply escalating all at-risk patients to the ED.
Our platform provides personalised and adaptive direction on treatment interventions, leveraging processed input data, including novel AI-driven algorithms and digital biomarkers.
Make informed clinical decisions across teams
Huma’s remote patient monitoring platform enables multiple teams and specialists to review patient data and clinician notes in a single platform, enabling improved clinician collaboration.
Data visualisation and overlay tools give clinicians dynamic information to help uncover patient insights. Our platform displays aggregated risk scores (e.g. NEWS2), allowing rapid prioritisation and patient triage.
Make informed clinical decisions across teams
Data visualisation and overlay tools give clinicians dynamic information to help uncover patient insights. Our platform displays aggregated risk scores (e.g. NEWS2), allowing rapid prioritisation and patient triage.
Improve outcomes across therapeutic areas
Huma’s EU MDR Class IIb regulated platform accommodates disease-specific configurations across diabetes, heart failure, cardiovascular disease, asthma, and many more therapeutic areas.
You can now monitor and support patients with multiple co-morbidities in order to better assess patient wellbeing. Huma provides smart, interactive, remote patient monitoring and symptom tracking support for a greater range of patients—including those with higher acuity conditions and comorbidities.
Regulatory, safety and compliance
MHRA registered Medical Device Class IIb
US Food and Drug Administration Medical Device 510k # K230214
ISO 13485: 2016 certified (Medical Devices: Quality Management Systems)
ISO 27001: 2013 certified
Committed to GDPR compliance
NHS Registration on Data Security and Protection Toolkit
CyberEssentials / CyberEssentials Plus
